[Results and considerations on the treatment of peripheral vascular diseases with a new product compounded by the salification of p-hydroxyphenylbutazone with 2-beta-hydroxyphenethylaminopyridine].

Source:http://linkedlifedata.com/resource/pubmed/id/6029506

Minerva Med. 1967 Apr 21 58 32 1435-9

Download in:

View as

General Info

PMID
6029506